Rezdiffra™ (resmetirom): a THR-β agonist for non-alcoholic steatohepatitis
Trends in Pharmacological Sciences · 2024-11 · 45 (11) · 1081-1082
DOI: 10.1016/j.tips.2024.08.009 ↗Kurz gefasst
Fachartikel in der Zeitschrift Trends in Pharmacological Sciences, 2024-11. Verfasst von Niki F Brisnovali und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine (Cardiology), Cardiovascular Research Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Die Arbeit wurde bisher 48-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, National Institutes of Health, National Heart Lung and Blood Institute.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Medicine (Cardiology), Cardiovascular Research Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
- Department of Medicine (Cardiology), Cardiovascular Research Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Department of Medicine (Endocrinology), Diabetes, Obesity, and Metabolism Institute, Ic…
Förderung
- NHLBI NIH HHS
- National Institutes of Health
- National Heart Lung and Blood Institute
Zitieren
APA
Brisnovali, N. F., Haney, C., & Goedeke, L. (2024). Rezdiffra™ (resmetirom): a THR-β agonist for non-alcoholic steatohepatitis. Trends in Pharmacological Sciences, 45(11), 1081-1082. https://doi.org/10.1016/j.tips.2024.08.009
Vancouver
Brisnovali NF, Haney C, Goedeke L. Rezdiffra™ (resmetirom): a THR-β agonist for non-alcoholic steatohepatitis. Trends in Pharmacological Sciences. 2024;45(11):1081-1082. doi:10.1016/j.tips.2024.08.009
BibTeX
@article{Brisnovali2024,
author = {Brisnovali, Niki F and Haney, Connor and Goedeke, Leigh},
title = {Rezdiffra™ (resmetirom): a THR-β agonist for non-alcoholic steatohepatitis},
journal = {Trends in Pharmacological Sciences},
year = {2024},
volume = {45},
number = {11},
pages = {1081--1082},
doi = {10.1016/j.tips.2024.08.009}
}
EUVIMED